Analysis |

Can Israel Actually Meet Netanyahu's Ambitious COVID-19 Vaccine Target?

First shipment already arrived, but getting it 
into millions of arms is a vastly complicated business

Send in e-mailSend in e-mail
Send in e-mailSend in e-mail

If the reports are correct, Israel is in debt to its prime minister, Benjamin Netanyahu. Pfizer and its partner BioNTech are said to be ready to supply the country with up to four million doses, enough for two million people by the end of December. The first shipment arrived on Wednesday.

Click the alert icon to follow topics:

Comments

SUBSCRIBERS JOIN THE CONVERSATION FASTER

Automatic approval of subscriber comments.
From $1 for the first month

SUBSCRIBE
Already signed up? LOG IN

ICYMI

בנימין נתניהו השקת ספר

Netanyahu’s Israel Is About to Slam the Door on the Diaspora

עדי שטרן

Head of Israel’s Top Art Academy Leads a Quiet Revolution

Charles Lindbergh addressing an America First Committee rally on October 3, 1941.

Ken Burns’ Brilliant ‘The U.S. and the Holocaust’ Has Only One Problem

Skyscrapers in Ramat Gan and Tel Aviv.

Israel May Have Caught the Worst American Disease, New Research Shows

ג'אמיל דקוור

Why the Head of ACLU’s Human Rights Program Has Regrets About Emigrating From Israel

ISRAEL-VOTE

Netanyahu’s Election Win Dealt a Grievous Blow to Judaism